GE releases low-dose CT technology

GE Healthcare’s Veo, a low-dose CT technology, recently received FDA 510(k) clearance and is now available in the U.S. The CT technology utilizes model-based iterative reconstruction, and is available on GE Discovery CT750 HD systems in Europe, Canada and parts of Asia.

Users in Europesaid that the chest CTs done with a Veo produce the same amount of medical radiation dose as a chest x-ray, according to GE. The company is coordinating a multicenter study to investigate new improvements, including substantially lower dose levels.


Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?